Clinical Relevance of Polymorphonuclear Myeloid-Derived Suppressor Cells in Autoimmune-Blistering Disorders Pemphigus Vulgaris and Bullous Pemphigoid

J Invest Dermatol. 2021 Mar;141(3):672-675.e1. doi: 10.1016/j.jid.2020.07.015. Epub 2020 Aug 10.

Authors

Ayse Oktem¹, Utku Horzum², Pelin Ertop³, Nihal Kundakci⁴, Bengu Nisa Akay⁴, Basak Yalcin⁵, Gunes Esendagli²

Affiliations

¹ Department of Dermatology, Faculty of Medicine, Ankara University, Ankara, Turkey. Electronic address: ayseoktem@yahoo.com.
² Department of Basic Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
³ Department of Dermatology, Bülent Ecevit University, Zonguldak, Turkey.
⁴ Department of Dermatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
⁵ Department of Dermatology, Ankara Bilkent City Hospital, Ankara, Turkey.

PMID: 32791069
DOI: 10.1016/j.jid.2020.07.015

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Cross-Sectional Studies
Female
Follow-Up Studies
Healthy Volunteers
Humans
Male
Middle Aged
Myeloid-Derived Suppressor Cells / immunology*
Pemphigoid, Bullous / immunology*
Pemphigoid, Bullous / pathology
Pemphigus / immunology*
Pemphigus / pathology
Skin / immunology
Skin / pathology*
Young Adult